The media monitor

Timothy Caulfield Credit: © Creative Services, University of Alberta" />Timothy Caulfield Credit: © Creative Services, University of AlbertaTimothy Caulfield has spent years listening to scientists complain that the media does a poor job of explaining science. As research director of the Health Law Institute at the University of Alberta, he has heard this so often, he says, that he started to believe it too. Finally, he decided to find o

Written byElie Dolgin
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Timothy Caulfield has spent years listening to scientists complain that the media does a poor job of explaining science. As research director of the Health Law Institute at the University of Alberta, he has heard this so often, he says, that he started to believe it too. Finally, he decided to find out for himself.

Caulfield pored over the print media's coverage of genetic discoveries from around the English-speaking world and compiled a list of 627 newspaper articles reporting on 111 different scientific journal articles. Together with a team of coders, all of whom had scientific backgrounds, he compared the newspaper articles with the original journal studies for signs of technical errors or exaggerated claims of the research findings.

Contrary to perceived opinions, he found that only 11% of the media stories could be categorized as inaccurate or exaggerated ( Can Med Assoc J, 170:1399-407, 2004). "I was genuinely surprised ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies